How does truly disruptive innovation occur? What are the key elements of a modern health startup ecosystem? In an era of unprecedented opportunity for creating health technology ventures around new ideas, it has never been more crucial to nurture ecosystems where entrepreneurs, clinicians, scientific researchers, investors, patients, and supporters can thrive together. These ecosystems can exist on multiple levels -- in particular fields, regions, cities, universities, or within organizations. I will share the story of building an accelerator for neuro-technology startups as an example of how universities like Georgia Tech can leverage their strengths to promote health technology startups in a global community. Together we will discover how the rapidly shifting landscape of health technology -- including AI, data science, genomics, population health, advanced imaging, and neuro-technology -- will provide the savviest innovators with exponentially increasing opportunities in the future.

Dr. Jordan Amadio is the co-founder of NeuroLaunch. He is an Innovation Fellow for the Congress of Neurological Surgeons, a recipient of the AMA Foundation's Excellence in Medicine Leadership Award, and among the “40 under 40” of MedTechBoston and the Atlanta Business Chronicle. Dr. Amadio earned degrees from Princeton, MIT, Harvard Medical School, and Harvard Business School. He was the Chief Resident in Neurosurgery at Emory University and served on the faculty of Exponential Medicine by Singularity University. He is currently an attending neurosurgeon at University of Texas Dell Seton Medical Center. NeuroLaunch was founded in 2014 with the mission to enable growth for startups focused on brain technology through direct investment, or by enabling rapid growth through its global community of entrepreneurs, pioneers, researchers, and leaders in neuroscience.